WeVote
Log In

Bill

Bill

HB 696

State Prescription Drug Benefits - Retirees

2026 Regular Session Introduced by Lauren Arikan and 6 co-sponsors

Maryland bill creating prescription drug benefits program for retirees to reduce medication costs for retired individuals through state-subsidized coverage.

Hearing 3/19 at 1:00 p.m.
0
WeVote Research Nonpartisan
Bill Summary · HB 696

Legislative bill overview

HB 696 would establish a state prescription drug benefits program specifically for retirees in Maryland. The bill appears to create or expand pharmaceutical coverage options for individuals who have retired from state employment or meet other eligibility criteria. The legislation was referred to the Appropriations Committee, indicating it involves state funding considerations.

Why is this important

Prescription drug costs represent a significant financial burden for retirees, particularly those on fixed incomes who may have gaps in Medicare coverage or high out-of-pocket costs. A state-level program could reduce healthcare expenses for this vulnerable population and potentially decrease reliance on emergency services when medications go unaffordable. The program's scope and funding mechanism will directly affect both retiree finances and the state budget.

Potential points of contention

  • Program cost and funding: The bill's fiscal impact on the state budget is unclear; taxpayers and legislators will debate whether this represents appropriate public spending versus private market solutions
  • Eligibility criteria: Defining who qualifies as a "retiree" (state employees only, all state residents over certain age, etc.) will determine program reach and cost
  • Interaction with federal programs: Questions about how this coordinates with Medicare, Medicaid, and existing drug benefit programs, and whether it duplicates or conflicts with federal initiatives

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.